Welcome : Guest

Kamada Ltd. (Israel) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Kamada Ltd., which is principally an Orphan Drug Focused, Plasma-Derived Protein Therapeutics Company. Illustrated with 57 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64715
Price: $2850
Company Type: Public
Pages: 65
Date: September 2016
Market Data Tables: 57

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Kamada Ltd.’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Proprietary Products, and Distribution......6
Table 2: Kamada Ltd.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Israel, U.S.A, Europe, Latin America, Asia, and Others......7
Alpha 1-antitrypsin (AAT)......10
Table 3: Alpha 1-antitrypsin (AAT) Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Aralast NP, Glassia IV, Prolastin Prolastin C, and Zemaira......10
Specialty Pharma & Orphan Drugs......11
Table 4: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......11
Factor IX (FIX)......12
Table 5: Factor IX (FIX) Consumption by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......12
Table 6: Factor IX (FIX) Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......13
Table 7: Factor IX (FIX) Consumption by Category in the US (2015) - Percentage Market Share Breakdown by Volume for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......14
Table 8: Factor IX (FIX) Sales by Category in the US (2015) - Percentage Market Share Breakdown by Value for Plasma-Derived FIX (PD FIX) and Recombinant FIX (r-FIX)......15
Factor VIII (FVIII)......16
Table 9: Factor VIII (FVIII) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Plasma-Derived (PD FVIII) and Standard r-FVIII (Recombinant FVIII)......16
Table 10: Factor VIII (FVIII) Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Plasma-Derived (PD FVIII) and Standard r-FVIII (Recombinant FVIII)......17
Table 11: Factor VIII (FVIII) Market by Category in the US (2015) - Percentage Share Breakdown by Volume Sales for Plasma-Derived (PD) FVIII and Standard r-FVIII (Recombinant FVIII)......18
Intravenous Immunoglobulin (IVIG)......19
Table 12: Intravenous Immunoglobulin (IVIG) Usage by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Hematology and Oncology, Immune Thrombocytopenic Purpura (ITP), Neurology, Pelvic Inflammatory Disease (PID), and Others......19
Table 13: Intravenous Immunoglobulin (IVIG) Therapy by Disorders in the US (2015) - Percentage Market Share Breakdown by No. of Indications for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Chronic Lymphocytic Leukemia (CLL), Idiopathic Thrombocytopenic Purpura (ITP), Mismatch Negativity (MMN), Pelvic Inflammatory Disease (PID), and Others......20
Plasma......21
Table 14: Plasma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Intravenous Immunoglobulin (IVIG), Specific Immunoglobulin and Others......21
Table 15: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......22
Table 16: Plasma Market by Products (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Factor VIII, Intravenous Immunoglobulin (IVIG) and Others......23
Table 17: Plasma Market by Region (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Europe, North America and Others......24
Table 18: Plasma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Europe, and Middle East, USA, and Others......25
Table 19: Blood Plasma Composition by Category Worldwide (2015) - Percentage Share Breakdown by Volume for Protein, Water, and Other......26
Table 20: Plasma Market by Segment in China (2015) - Percentage Share Breakdown by Value for Alpha-1 proteinase inhibitor (A1PI), Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Immunoglobulin for Intramuscular Injection, Intravenous Immunoglobulin (IVIG), Prothrombin Complex, and Specific Immunoglobulin......27
Table 21: Plasma Market by Type in China (2015) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Fibrinogen, Human Albumin, Human Immunoglobin and Hyperimmunes......28
Table 22: Plasma Product Market by Category in the US (2015) - Percentage Share Breakdown by Value for Clothing Factors, Human Albumin, and Various Types of Immunoglobulin......29
Plasma Derivatives......30
Table 23: Plasma Derivatives Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America, and Others......30
Table 24: Plasma Derivatives Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Albumin, Alpha-1 Proteinase Inhibitor (A1PI), Hyperimmune, Intravenous Immunoglobulin (IVIG), Plasma-Derived Factor VIII (PDFVIII) & Willebrand Factor (WFactor), Polymeric Immunoglobulin Receptor, and Others......31
Plasma Products......32
Table 25: Plasma-Based Product Market by Type in China (2015) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Human Albumin, Human Immunoglobin, Hyperimmunes, and Others......32
Table 26: Plasma Products Consumption by Type in China (2015) - Percentage Share Breakdown by Volume for Albumin, Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG)......33
Table 27: Plasma Products Consumption by Type in the US (2015) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......34
Plasma Proteins......35
Table 28: Plasma Proteins Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Globulins and Others......35
Table 29: Plasma Proteins Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Africa, Asia-Pacific, Europe, Middle East, North America, Oceania, and South America......36
Albumin......37
Table 30: Market Shares of Leading Albumin Providers in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group (CNBG), CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co., Ltd., Ningbo Shuanglin Mould Co., Ltd., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Tonrol Biopharm Co., Ltd., and Others......37
Table 31: Market Shares of Leading Intravenous Immunoglobulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Ningbo Shuanglin Mould Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......38
Table 32: Market Shares of Leading Human Albumin Manufacturers in China (2015) - Percentage Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., CSL Behring LLC, Grifols S.A. and Others......39
Table 33: Market Shares of Leading Human Albumin Companies in China (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co., Ltd., China Biologic Products, Inc., CSL Behring, Grifols, S.A., and Others......40
Table 34: Market Shares of Leading Albumin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., Kedrion S.p.A, and Octapharma AG......41
Alpha 1-Antitrypsin (AAT)......42
Table 35: Market Shares of Leading Alpha 1-Antitrypsin (AAT) Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., CSL Ltd., Grifols, S.A., and Others......42
Factor VIII......43
Table 36: Market Shares of Leading Factor VIII Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Kedrion S.p.A......43
Hepatitis B Immune Globulin......44
Table 37: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Boya Medical Equipment Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......44
Immunoglobulin......45
Table 38: Market Shares of Leading Immunoglobulin Providing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc. (Gammagard Liquid and S/D), CSL Limited (Privigen, Carimune and Hizentra), Grifiols, S.A. (Flebogamma and Gamunex) and Others......45
Intravenous Immunoglobulin (IVIG)......46
Table 39: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A, LFB Group, Octapharma AG, and Others......46
Table 40: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A., Octapharma AG and Others......47
Table 41: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Therapy Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Biotest AG, CSL Limited, Grifols, S.A., Talecris Biotherapeutics, Inc., Kedrion S.p.A., Octapharma AG, and Others......48
Table 42: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......49
Table 43: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......50
Rabies Immune Globulin......51
Table 44: Market Shares of Leading Rabies Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co., Ltd., Ningbo Shuanglin Mould Co., Ltd., Shuyang Group, Tonrol Biopharm Co., Ltd., and Others......51
Plasma......52
Table 45: Market Shares of Leading Plasma Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Limited, Grifols, S.A. and Others......52
Table 46: Market Shares of Leading Plasma Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., CSL Plasma, Inc., Grifols, S.A., Octapharma AG, and Others......53
Table 47: Market Shares of Leading Plasma Companies in China (2014) - Percentage Share Breakdown by Volume for Chengdu Rongsheng Pharmaceuticals Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Tonglu Biological Pharmaceutical Co., Ltd., and Others......54
Table 48: Market Shares of Leading Plasma Fractionators in China (2015) - Percentage Share Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Shuyang Group and Others......55
Table 49: Market Shares of Leading Plasma Manufacturers in China (2015) - Percentage Breakdown by Volume for Guizhou Taibang Biological Products Co., Ltd. and Shandong Taibang Biological Products Co.,Ltd.......56
Table 50: Market Shares of Leading Plasma Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Behring, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......57
Plasma Derivatives......58
Table 51: Market Shares of Leading Plasma Derivative Companies Worldwide (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Grilfols USA, Kedrion Biopharma, LFB, Octapharma AG, and Others......58
Table 52: Market Shares of Leading Plasma Derivative Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL, Ltd., Grilfols USA, and Octapharma AG......59
Plasma Proteins......60
Table 53: Market Shares of Leading Plasma Protein Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL Ltd., Grifols, S.A., Octapharma AG, and Other......60
Table 54: Market Shares of Leading Plasma Protein Product Producers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Biotest AG, CSL Ltd., Grifols, S.A., Kedrion S.p.A, LFB Group, Octapharma AG, Shire Plc, and Others......61
Table 55: Market Shares of Leading Plasma Protein Product Producers in the US (2015) - Percentage Breakdown by Volume for Baxter International, Inc., CSL Ltd., Grifols, S.A., and Others......62
Table 56: Kamada Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Israel, U.S.A, Europe, Latin America and Others......63
Table 57: Kamada Ltd.’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Proprietary Products and Distribution......64